In this episode of Investor Insights, Ken Dropiewski sits down with Jason Lettmann about Lightstone ventures and the MedTech/Life Science industry including Colorado.
Author: Ken Dropiewski
Cardiovascular Systems, Inc. Reports Fiscal 2021 Third-Quarter Financial Results
Conference Call Scheduled for Today, May 6, 2021, at 3:30 PM CT (4:30 PM ET) Revenues of $63.3 million increased 3.4% compared to third quarter last year Net loss of $6.0 million includes $3.4 million related to acquisition of peripheral support catheters from WavePoint Medical, LLC Management provides fiscal 2021 […]
iRhythm Technologies Announces First Quarter 2021 Financial Results
SAN FRANCISCO, May 06, 2021 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today reported financial results for the three months ended March 31, 2021. First Quarter 2021 Financial Highlights Revenue was $74.3 million, a 17% […]
Prevent Heart Disease, Interview With Dr. Rajiv Agarwal of Modern Heart & Vascular Institute
Dr. Rajiv Agarwal (Cardiologist) with Modern Heart & Vascular Institute discusses who should get heart screening and how the latest technology can help. HOUSTON, May 7, 2021 /PRNewswire/ — In April, 2021, Dr. Rajiv Agarwal, board-certified cardiologist at Modern Heart and Vascular Institute, talked about the importance of heart screening. He helped clear up some myths […]
Neovasc Announces First Quarter 2021 Financial Results
VANCOUVER and MINNEAPOLIS, May 06, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), today reported financial results for the first quarter ended March 31, 2021. First Quarter Highlights Generated revenue of $451,794 in the quarter as Neovasc Reducer™ implants rebounded after being suppressed for much of 2020 […]
Cytokinetics Reports First Quarter 2021 Financial Results
Secondary Analysis from GALACTIC-HF to be Presented in Late Breaking Clinical Trial Session at ACC.21 Company Plans to Submit NDA for Omecamtiv Mecarbil following Recent Meeting with FDA Results from REDWOOD-HCM Expected Mid-Year; Open Label Extension Study and Phase 3 Clinical Trial Planning Underway SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) […]
Lexicon Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Clinical Update
Conference Call and Webcast at 5:00 pm Eastern Time THE WOODLANDS, Texas, May 06, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), today reported financial results for the three months ended March 31, 2021 and provided an update on key milestones. “We continue to enroll patients in our two proof-of-concept Phase […]
Caladrius Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
Conference call begins today at 4:30 p.m. Eastern Time BASKING RIDGE, N.J. , May 06, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, provides a corporate update and reports financial […]
Xenter, Inc. Appoints Industry Leaders Robert S. Langer, Elazer R. Edelman, David J. Bearss and Mark Stautberg to Board of Directors; Closes $12M Series A
-Xenter’s Expanding Team of Industry Leaders Poised to Advance Device/Data/Drug Technologies for Interventional Medicine, Pharmaceutical Advancements and Digital Health- SALT LAKE CITY–(BUSINESS WIRE)–Xenter, Inc. (XenterMD.com), the world’s first start-up Device-Data-Drug healthcare technologies company, today announced the appointment of four additional industry leaders to its Board of Directors and the closing of […]
Acceleron Reports First Quarter 2021 Financial Results
– PULSAR Phase 2 trial results published in New England Journal of Medicine – – Updates from the PULSAR and SPECTRA Phase 2 trials of sotatercept in patients with pulmonary arterial hypertension (PAH) to be presented at the American Thoracic Society (ATS) 2021 International Conference on May 19, 2021 – […]
Recent
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu
Atrium Therapeutics Reports First Quarter 2026 Financial Results
Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance
Popular
- No commented posts yet